Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data

Published: 12 September 2022| Version 1 | DOI: 10.17632/j6ys2x8g4g.1
Contributors:
Rod Sinclair,
Sammy Sharifeh,
Susan Thackwray,
Jason Lickliter,
Junlong Wu,
Jing Li,
Bei Qi,
Philip Bland-Ward,
Harald Reinhart

Description

Supplementary methods, tables and figures

Files

Categories

Cytokines, General Dermatology, Medical Dermatology, Immunodermatology, Psoriasis

License